Through analysis of the public available breast cancer survival data (http://kmplot.com/analysis/), we observe that SHARPIN expression correlates with poor relapse-free survival in ERα positive breast cancer patient groups of GSE 7390 dataset, GSE6532 dataset and GSE17705 dataset (Figure 2A). The gene discussed is SHARPIN; the disease is breast carcinoma.